Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ![]() Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. | |
Founding Date | Founding Date 1978 | Founding Date 2002 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU |
Employees | Employees 7,605 | Employees 58415% increase | Employees 105 |
Valuation ($) | Valuation ($) 26.7 b | Valuation ($) 3.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $2.4b (FY, 2025) | Cost of goods $72.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $7.5b (FY, 2025) | Gross profit $561.3m (FY, 2025) | Gross profit N/A |
Net income | Net income $1.3b (FY, 2025) | Net income ($27.1m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 7.5m |

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
View company